Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
251.00    5.50 (2.24%)
Bid:
247.00
Ask:
248.00
Spread: 1.00 (0.405%)
Market Cap: £146.42m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Result of AGM

3 Dec 2020 13:44

RNS Number : 4903H
MJ Gleeson PLC
03 December 2020
 

MJ GLEESON plc

Incorporated in England and Wales

Registration number: 09268016

LEI: 21380064K7N2W7FD6434

ISIN: GB00BRKD9Z53

 

 

 

MJ Gleeson plc

("the Company")

 

 

MJ Gleeson plc - Annual General Meeting Results

 

The Company held its Annual General Meeting at 11:00am on Thursday 3rd December 2020, as a closed meeting at 6 Europa Court, Sheffield Business Park, Sheffield S9 1XE (the "AGM").

 

All resolutions put to the meeting were voted on by way of a poll and were passed by the shareholders. The following table gives results of the poll vote:

 

Votes For

Votes Against

Votes Withheld

Total Votes Cast

Resolution

No. of shares

% of shares voted

No. of shares

% of shares voted

No. of shares

No. of shares

% of issued share capital

1

To receive and adopt the Report of the Directors and the financial statements together with the Independent Auditors' Report for the year ended 30 June 2020

45,775,660

99.89

 

51,562

 

 

0.11

 

 

1,957

 

 

45,827,222

 

78.67%

2

To re-appoint Dermot Gleeson as a Director

43,761,829

95.5

2,061,178

4.5

9,132

45,823,007

78.66%

3

To re-appoint Andrew Coppel as a Director

45,187,941

98.6

642,203

1.4

1,995

45,830,144

78.67%

4

To re-appoint Fiona Goldsmith as a Director

45,188,111

98.6

642,033

1.4

1,995

45,830,144

78.67%

5

To re-appoint Christopher Mills as a Director

38,741,267

84.55

7,081,740

15.45

9,132

45,823,007

78.66%

6

To re-appoint James Thomson as a Director

45,824,601

99.99

5,543

0.01

1,995

45,830,144

78.67%

7

To re-appoint Stefan Allanson as a Director

45,816,166

99.97

13,978

0.03

1,995

45,830,144

78.67%

8

To re-appoint PricewaterhouseCoopers LLP as Independent Auditor

45,810,325

99.96

19,819

0.04

1,995

45,830,144

78.67%

9

To authorise the Directors to determine the Independent Auditor's remuneration

45,824,519

99.99

5,663

0.01

1,957

45,830,182

78.67%

10

To approve the Annual Report on Remuneration

27,757,341

60.66

18,002,509

39.34

72,289

45,759,850

78.55%

11

To authorise the Directors to allot shares in the Company pursuant to Section 551 of the Companies Act 2006

45,756,316

99.85

69,552

0.15

6,271

45,825,868

78.66%

12

To disapply pre-emption rights in connection with a rights issue

45,496,816

99.28

328,302

0.72

7,021

45,825,118

78.66%

13

To disapply pre-emption rights in connection with allotment of equity securities or sale of treasury shares

45,490,145

99.27

334,972

0.73

7,021

45,825,117

78.66%

14

To authorise the Company to purchase its own shares under Section 701 of the Companies Act 2006

45,563,986

99.43

261,881

0.57

6,271

45,825,867

78.66%

15

To authorise the Company to call General Meetings other than Annual General Meetings on not less than 14 clear days' notice

45,466,982

99.21

361,300

0.79

3,857

45,828,282

78.67%

 

Resolution 10:

 

Whilst the Board welcomes the strong level of support for the resolutions put to the Meeting, it notes that resolution 10 (to approve the Directors' Remuneration Report) was passed with 60.66% of votes cast.

 

The Company engaged with shareholders and the relevant proxy advisory companies in advance of the AGM and fully understands the issues of primary concern. However, Andrew Coppel, as the recently appointed Chairman of the Remuneration Committee, will undertake a wider engagement with shareholders as part of the Committee's review of the Company's overall remuneration policy ahead of publishing its next report. The Board will provide an update no later than 6 months' time.

 

 

* Includes discretionary votes

 

Notes:

 

(1) A "vote withheld" is not a vote in law and is not counted in the total number of votes cast for or against a resolution.

 

(2) Resolutions 1-11 were ordinary resolutions and resolutions 12-15 were special resolutions.

 

Copies of the special business resolutions passed at the Annual General Meeting will shortly be available for inspection via the Financial Services Authority's National Storage Mechanism in accordance with 9.6.2(R) of the Listing Rules

 

There were 58,255,788 ordinary shares of 2p each in issue on 3 December 2020.

 

Further information is available from:

 

MJ Gleeson plc

Stefan Allanson

Chief Financial Officer

Tel: 01142 612900

Leanne Johnson

Company Secretary

Tel: 01142 612900

 

3 December 2020

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDZMGZFFZGGZM
Date   Source Headline
9th Jun 20262:17 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSUpdate on Gleeson Land
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.